Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy pens hold 0.75ml or 1.5ml of solution, not 5ml — so if you've spotted "5ml" on packaging or a label, it almost certainly refers to the secondary container or a pharmacy supply unit, not the dose you inject. Wegovy (semaglutide) is a prescription-only medicine requiring clinical assessment before it can be dispensed. Here's how to read your pen correctly and what to do if something looks off.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy pens are pre-filled and pre-set. Each pen contains a fixed volume of semaglutide solution, 0.75ml for the 0.25mg and 0.5mg dose pens, and 1.5ml for the 1.0mg, 1.7mg and 2.4mg pens. Those two figures are the ones printed on the pen's label itself.
A "5ml" figure appearing on an outer carton or a dispensing bag is a different number entirely. It typically relates to the combined fill volume of a multi-pen supply batch, a pharmacy transfer container, or a stock unit used within the licensed UK supply chain, and our Wegovy 5ml page explains exactly what that figure represents and where it comes from. It is not your injection volume and it does not represent a dose. If you're reading it on the pen body rather than the outer packaging, that's worth a call to your pharmacist, the NHS medicines page for semaglutide on NHS.uk describes what standard Wegovy pens look like and what their labels should contain.
A practical check you can do in under a minute: hold the pen label next to the product information leaflet inside the box. The strength printed on the pen (for example, 1.7mg/0.75ml or 2.4mg/1.5ml) should match what your prescription and the leaflet describe. If it doesn't, set it aside and contact your pharmacy before injecting.
Wegovy treatment starts at 0.25mg once weekly. The prescriber then steps the dose up roughly every four weeks: 0.25mg, then 0.5mg, 1.0mg, 1.7mg, and finally 2.4mg as the standard maintenance dose. Since January 2026 a 7.2mg maintenance option has been available following MHRA approval, though this is not appropriate for everyone and the starting dose remains 0.25mg regardless.
None of those dose figures map to a "5ml" measurement. The milligram figure on the pen is the one that matters clinically. If you want a plain-English summary of how the semaglutide schedule works and why the early doses are gentler, our semaglutide guide walks through the pharmacology without the jargon.
Your prescriber sets each step based on how your body is tolerating the current dose. Skipping steps, changing your timing, or repeating a dose are decisions for the prescriber and the Patient Information Leaflet, not something to adjust based on what's printed on the carton.
This matters. The MHRA has issued repeated warnings about counterfeit and illegally traded weight-loss pens sold online, and some fakes have been physically indistinguishable from genuine pens on first inspection. A reputable UK pharmacy (one you can look up on the GPhC register) sources Wegovy through the authorised Novo Nordisk supply chain. Unexpected labelling, unfamiliar volume figures, or packaging that doesn't match the Patient Information Leaflet are all reasons to pause.
If you transferred to Wegovy from Saxenda and are comparing what the two pen formats look like, our Saxenda-to-Wegovy guide covers the physical differences between the two products. They are not interchangeable and the pen designs differ.
Genuine Wegovy pens are refrigerated at 2–8°C and should arrive cold. Check them against the Patient Information Leaflet for appearance and labelling before your first injection. Questions about what you've received are exactly the kind of thing a pharmacist should field promptly, don't inject if something doesn't look right.
Unexpected markings on a medicine are a legitimate concern, and prescribers hear this kind of question regularly. It is not a trivial thing to ask. If you are a patient at a regulated online pharmacy and something about the pen labelling or volume figure doesn't match what you expected, your pharmacy's aftercare team is the first port of call.
If you're still weighing up whether Wegovy is the right option for you, or wondering how the injection version compares with newer formats, the Wegovy overview page covers the full picture: licence, eligibility, trial evidence and how the NHS access route differs from a private prescription. For a straightforward cost comparison of what private treatment typically involves, our Wegovy pricing guide explains what the numbers on a quote usually do and don't include.
And if needles are part of what's giving you pause, you're not alone. Our guide for people nervous about starting Wegovy addresses the practicalities honestly. When you're ready to talk through your situation with a clinician, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.